J. Hilden

发表

Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

E. Bedrick, R. Stam, R. Pieters, 2012, Blood.

Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation

C. Dandoy, B. Mueller, J. Hilden, 2017, Springer International Publishing.

Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.

M. Mehta, T. Zhou, I. Pollack, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increasing diversity in pediatric hematology/oncology

K. Sakamoto, J. Lakoski, J. Lipton, 2011, Pediatric blood & cancer.

Transplantation of Major ABO‐Incompatible Bone Marrow Depleted of Red Cells by Hydroxyethyl Starch 1

J. Kersey, J. Hilden, N. Ramsay, 1985, Vox sanguinis.

Transient monosomy 7

K. Shannon, J. Finklestein, E. Mantadakis, 1999, Cancer.

Pediatric palliative care.

D. Weissman, J. Hilden, B. Himelstein, 2004, The New England journal of medicine.

Central Nervous System Atypical Teratoid Tumor/Rhabdoid Tumor: Response to Intensive Therapy and Review of the Literature

B. Scheithauer, J. Kurtzberg, C. Moertel, 1998, Journal of Neuro-Oncology.

Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

B. Scheithauer, J. Biegel, L. Rorke, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: Report on Workshop

J. Biegel, L. Rorke, J. Finlay, 2002, Journal of pediatric hematology/oncology.

Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

C. Hawkins, S. Baruchel, D. Hargrave, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Birth Characteristics, Maternal Reproductive History, and the Risk of Infant Leukemia: A Report from the Children's Oncology Group

L. Robison, J. Ross, S. Davies, 2007, Cancer Epidemiology Biomarkers & Prevention.

The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2—Implications for fellowship training

P. Leavey, C. Dandoy, S. Badawy, 2018, Pediatric blood & cancer.

Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements.

M. Dittmar, N. Goldenberg, B. Branchford, 2017, Thrombosis research.

Concurrent Epstein‐Barr Virus Associated Non‐Hodgkin Lymphoma and Recurrent Hodgkin Disease

J. Manivel, J. Hilden, N. Ramsay, 1996, Journal of pediatric hematology/oncology.

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.

P. Vyas, Q. Wen, C. Fisher, 2007, Blood.

Brain tumors in children

A. Walter, J. Hilden, 2004, Current oncology reports.

Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407

S. Hunger, M. Devidas, N. Winick, 2012, Pediatric blood & cancer.

Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomas

V. Mathews, D. Heilman, T. Luerssen, 2000 .

Fatigue in children with cancer at the end of life.

J. Wolfe, V. Dussel, C. Berde, 2010, Journal of pain and symptom management.

Advances in Brief Heterogeneity in MLL / AF-4 Fusion Messenger RNA Detected by the Polymerase Chain Reaction in t ( 4 ; ll ) Acute Leukemia 1

C. Chen, J. Kersey, J. Hilden, 2006 .

The Chromosome 4 q 21 Gene ( AF-4 / FEL ) Is Widely Expressed in Normal Tissues and Shows Breakpoint Diversity in t ( 4 ; 1 l ) ( q 21 ; q 23 ) Acute Leukemia

Stanley, C. Chen, P. Domer, 2003 .

Differential expression of AF4/FEL mRNA in human tissues.

J. Frestedt, J. Hilden, R. Moore, 1996, Genetic analysis : biomolecular engineering.

The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studies.

J. Hilden, J. Kersey, 1994, Leukemia & lymphoma.

The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues and shows breakpoint diversity in t(4;11)(q21;q23) acute leukemia

S. Korsmeyer, C. Chen, J. Kersey, 1993 .

MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: A Children's Oncology Group (COG) study

Kimberly J. Johnson, N. Heerema, G. Reaman, 2012, Pediatric blood & cancer.

Gene expression proﬁles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children’s Oncology Group study

E. Bedrick, R. Stam, R. Pieters, 2012 .

High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.

Raymund B. Dantes, D. Frank, C. Gould, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of Infectious Complications in Infants With Acute Lymphoblastic Leukemia Treated on the Children's Cancer Group Protocol 1953: A Report From the Children's Oncology Group

G. Reaman, Z. Dreyer, J. Hilden, 2009, Journal of pediatric hematology/oncology.

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971

R. Arceci, T. Alonzo, R. Gerbing, 2012, Cancer.

MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia.

I. Bernstein, J. Buckley, W. Woods, 1997, Blood.

Risk factors for bacteremia and central line–associated blood stream infections in children with acute myelogenous leukemia: A single‐institution report

J. Gralla, Suhong Tong, S. Dominguez, 2017, Pediatric blood & cancer.

Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia

N. Heerema, D. Teachey, A. Seif, 2018, Oncogene.

Considerations about hastening death among parents of children who die of cancer.

S. Joffe, J. Weeks, J. Wolfe, 2010, Archives of pediatrics & adolescent medicine.

Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey.

E. Emanuel, D. Fairclough, K. Foley, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Looking beyond where children die: determinants and effects of planning a child's location of death.

J. Weeks, J. Wolfe, V. Dussel, 2009, Journal of pain and symptom management.

Tell the children.

J. Hilden, J. Chrastek, J. Watterson, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.

R. Arceci, T. Alonzo, R. Gerbing, 2011, Blood.

End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care.

J. Wolfe, V. Dussel, L. Lehmann, 2010, Blood.

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.

J. Neglia, H. Sather, B. Druker, 2002, Blood.

Infant leukemia and congenital abnormalities: A Children's Oncology Group study

Kimberly J. Johnson, J. Ross, S. Davies, 2010, Pediatric blood & cancer.

A Quality Initiative to Decrease Time to Antibiotics in Children with Sickle Cell Disease and Fever

R. Nuss, J. Hilden, Kathleen E. Montgomery, 2020, Pediatric quality & safety.

Molecular analysis of infant acute leukemia.

J. Kersey, J. Frestedt, J. Hilden, 1997, Leukemia & lymphoma.

The ABCs of infant leukemia.

J. Hilden, P. Zweidler-McKay, 2008, Current problems in pediatric and adolescent health care.

nfant AML : The Highest Incidence n Infants

J. Hilden, P. Zweidler-McKay, 2008 .

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

N. Heerema, W. Woods, H. Sather, 2006, Blood.

Maternal exposure to household chemicals and risk of infant leukemia: a report from the Children’s Oncology Group

Kimberly J. Johnson, N. Heerema, L. Robison, 2011, Cancer Causes & Control.

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

Kajia Cao, Mondira Kundu, Li-San Wang, 2013, Blood.

Introduction to Patient Safety and Quality in the Pediatric/Hematology Oncology and Hematopoietic Stem Cell Transplant Practice

C. Dandoy, B. Mueller, J. Hilden, 2017 .

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome

P. Vyas, C. Eng, K. Theil, 2007, Nature Clinical Practice Oncology.

Genetic variants modify susceptibility to leukemia in infants: A Children's Oncology Group report

N. Heerema, J. Ross, S. Davies, 2013, Pediatric blood & cancer.

Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG

M. Loh, N. Heerema, B. Wood, 2018, Haematologica.

Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23).

N. Heerema, D. Arthur, G. Reaman, 1995, Blood.

Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.

Douglas C. Miller, T. Zhou, S. Ingles, 2015, Pediatric neurology.

rearrangement and reverse transcriptase-polymerase chain reaction Molecular analysis of infant acute lymphoblastic leukemia: MLL gene

D. Arthur, G. Reaman, J. Frestedt, 2011 .

AF4/FEL, a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31.

J. Frestedt, J. Hilden, J. Kersey, 1996, DNA and cell biology.

Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia.

J. Kersey, J. Frestedt, J. Hilden, 1993, Cancer research.

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631

M. Loh, N. Heerema, S. Hunger, 2021, Leukemia.

Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group

J. Potter, N. Heerema, C. Felix, 2005, Cancer Epidemiology Biomarkers & Prevention.

The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.

I. Bernstein, D. Williams, J. Buckley, 1996, Blood.

Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)

F. Behm, N. Heerema, C. Felix, 2015, Pediatric blood & cancer.

Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?

J. Hilden, A. Gamis, 2002, Journal of pediatric hematology/oncology.

Outcome of Down Syndrome (DS) Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Treated with a Uniform Prospective Clinical Trial - Initial Report of the COG Trial A2971.

R. Arceci, T. Alonzo, R. Gerbing, 2006 .

Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group

M. Loh, R. Pieters, S. Hunger, 2015, Pediatric blood & cancer.

A multidisciplinary approach to the management of anterior mediastinal masses in children.

T. Garrington, D. Partrick, L. Hoffman, 2015, Journal of pediatric surgery.

Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

F. Behm, N. Heerema, W. Woods, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.

N. Heerema, W. Woods, H. Sather, 2005 .

Parents' views of cancer-directed therapy for children with no realistic chance for cure.

S. Joffe, J. Weeks, J. Wolfe, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Parent and physician perspectives on quality of care at the end of life in children with cancer.

J. Weeks, J. Wolfe, H. Grier, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high‐risk stratum of patients with newly diagnosed high‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131

M. Loh, N. Heerema, B. Wood, 2018, Cancer.

Navigating your career path in pediatric hematology/oncology: On and off the beaten track

K. Sakamoto, R. Jubran, J. Franklin, 2016, Pediatric blood & cancer.

One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children.

C. Moertel, B. Bostrom, M. O'Leary, 1997, Journal of pediatric hematology/oncology.

The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1—Current state of the workforce

S. Badawy, J. Hilden, A. Wayne, 2018, Pediatric blood & cancer.

Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program

K. Myers, S. Badawy, J. Hilden, 2017, Pediatric blood & cancer.

Caring for children with advanced cancer integrating palliative care.

J. Wolfe, J. Hilden, S. Friebert, 2002, Pediatric clinics of North America.

Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.

J. Weeks, J. A. Heath, J. Wolfe, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High Risk B-Lymphoblastic Leukemia: Results of Children's Oncology Group Study AALL1131

M. Loh, N. Heerema, B. Wood, 2018, Blood.

Down Syndrome Patients with Relapsed Acute Myelogenous Leukemia.

T. Alonzo, R. Gerbing, W. Woods, 2004 .

Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.

V. Mathews, D. Heilman, T. Luerssen, 2000, Journal of neurosurgery.

Complementary and alternative medicine in pediatric oncology: Availability and institutional policies in Canada—a report from the Children's Oncology Group

D. Johnston, K. Kelly, D. Friedman, 2006, Pediatric blood & cancer.

Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.

Raymund B. Dantes, B. Limbago, L. Pollack, 2016, American journal of infection control.

Cancer care during the last phase of life.

D. S. Gordon, J. Hilden, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131.

M. Loh, N. Heerema, B. Wood, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Issues and challenges in palliative care for children with cancer

D. Friedman, J. Hilden, K. Powaski, 2005, Current pain and headache reports.

Issues and challenges in palliative care for children with cancer

D. Friedman, J. Hilden, K. Powaski, 2004, Current oncology reports.

Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs

J. Hilden, Michael Rannie, Rebecca Coughlin, 2015, Pediatric blood & cancer.

It is Time to Let in Pediatric Palliative Care

J. Hilden, 2016, Pediatric blood & cancer.

Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients

D. Frank, C. Robertson, D. Ir, 2018, PloS one.

Incidence of Allergic Reactions to Pegaspargase (PEG) Administered Intramuscularly Versus Intravenously (IM vs. IV) in Children and Young Adults with High Risk B-Lymphoblastic Leukemia (HR B-ALL): Results of Children's Oncology Group (COG) Studies AALL0232/AALL1131

M. Loh, S. Hunger, M. Devidas, 2015 .

Outstanding outcomes in infants with KMT2Agermline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial

M. Loh, N. Heerema, S. Hunger, 2022, Haematologica.

End-Of-Life Experience Of Children Undergoing Stem Cell Transplantation For Malignancy: Parent And Provider Perspectives And Patterns Of Care

J. Wolfe, V. Dussel, L. Lehmann, 2010 .

End-of-Life Experience of Children Undergoing Stem Cell Transplantation: Parent and Provider Perspectives and Patterns of Care.

J. Wolfe, V. Dussel, L. Lehmann, 2009 .

Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: Report on Workshop

J. Biegel, L. Rorke, J. Finlay, 2002 .

Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group

N. Heerema, J. Ross, S. Davies, 2010, British Journal of Cancer.

Excess congenital non-synonymous variation in leukemia-associated genes in MLL− infant leukemia: a Children's Oncology Group report

T. Druley, N. Heerema, J. Ross, 2013, Leukemia.

Hematopoietic stem cell transplant (HSCT) versus intensive chemotherapy in infant acute lymphoblastic leukemia (ALL)

N. Heerema, M. Devidas, G. Reaman, 2007 .

KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.

F. Behm, N. Heerema, C. Felix, 2023, Haematologica.

Arandomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia : a Children ’ s Cancer Group study

J. Neglia, H. Sather, B. Lange, 2002 .